Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Smoking Cessation, Acute Coronary Syndrome
Interventions: Behavioral Activation (BA), Standard Smoking Cessation Counseling, Nicotine patch, Printed Self-help materials for Smoking Cessation; Behavioral · Drug · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Healthy
Interventions: Tetrix; Device
Lead sponsor: Coria Laboratories, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Nicotine Dependence
Interventions: Dual nicotine patch and electronic cigarette; Other
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Peripheral Arterial Disease, Claudication
Interventions: Visi-Pro™ Balloon Expandable Stent System; Device
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Teaneck, New Jersey

Conditions: Central Line Bloodstream Infections
Interventions: Silver Alginate; Device
Lead sponsor: Baylor Research Institute; Other
Eligibility: 1 Day to 3 Weeks
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Tobacco Use Disorder
Interventions: Brief Negotiated Interview (BNI), Nicotine replacement therapy (NRT), CT Smokers Quitline (QL), SmokefreeText (Text); Behavioral · Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,056 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Breast Cancer
Interventions: NIR/US Diagnostic Group, NIR/US Neoadjuvant Chemotherapy Group, NIR/US Process Validation Group; Other
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Acute Pain
Interventions: Diclofenac Sodium Patch, Matching Placebo Patch; Drug
Lead sponsor: Cerimon Pharmaceuticals; Industry
Eligibility: 17 Years to 75 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Prostate Cancer
Interventions: MRI Guided Focal Laser Interstitial Thermal Ablation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Dermatologic Diseases
Interventions: non-invasive sample collection of skin tissue; Other
Lead sponsor: DermTech; Other
Eligibility: 21 Years and older
Enrollment: 1,000 participants
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Denver, Colorado • Boca Raton, Florida

Conditions: Dermatitis, Atopic
Interventions: AN2728 Topical Ointment, 2% QD, AN2728 Topical Ointment, 0.5% QD, AN2728 Topical Ointment, 2% BID, AN2728 Topical Ointment, 0.5% BID; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 11
States / cities: Fremont, California • Miami, Florida • Lousiville, Kentucky + 8 more

Conditions: Peripheral Arterial Disease, Claudication
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 12
States / cities: Bellevue, Washington • Bellingham, Washington • Everett, Washington + 6 more

Conditions: Metastatic Renal Cell Carcinoma ( mRCC), OligoProgressive Metastatic Disease
Interventions: IMSA101; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cavities of Teeth
Interventions: Silver Diamine Fluoride, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 12 Months to 71 Months
Enrollment: 830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Iowa City, Iowa • Ann Arbor, Michigan • New York, New York

Conditions: Laryngeal Diseases
Interventions: CO2 laser; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 88 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Peripheral Pulmonary Lesions (PPLs), Lung Nodules
Interventions: Bronchoscopy for peripheral pulmonary lesion biopsy; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois • Cleveland, Ohio

Conditions: Depressive Disorder
Interventions: Transdermal Nicotine patch; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Superficial Basal Cell Carcinoma
Interventions: API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo; Drug · Other
Lead sponsor: BPGbio; Industry
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 11
States / cities: Hot Springs, Arkansas • San Diego, California • Denver, Colorado + 8 more

Conditions: Osteosarcoma, Pulmonary Recurrence of Osteosarcoma
Interventions: Surgical Resection, Stereotactic Body Radiation Therapy (SBRT), Atezolizumab; Procedure · Radiation · Drug
Lead sponsor: Emory University; Other
Eligibility: Up to 50 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Coronary Artery Disease, Coronary Artery Chronic Total Occlusion
Interventions: Crossing of Coronary Artery CTO; Device
Lead sponsor: Asahi Intecc USA Inc; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 12
States / cities: Phoenix, Arizona • Loveland, Colorado • Atlanta, Georgia + 8 more

Conditions: End Stage Renal Disease
Interventions: Venography, Intravascular ultrasound (IVUS), Image processing; Diagnostic Test · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carotid Stenosis, Stroke, Carotid Artery Plaque, Transient Ischemic Attack, Cerebrovascular Accident, Carotid Artery Stenosis
Interventions: Carotid Endarterectomy or Stenting; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Oral Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma, Premalignant Lesion
Interventions: OralViome Cancer Testing System; Device
Lead sponsor: Viome; Industry
Eligibility: 18 Years and older
Enrollment: 475 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Melanoma
Interventions: 852A; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 2
States / cities: Lebanon, New Hampshire • Oklahoma City, Oklahoma

Search by objective public record fields.

Post Acute Coronary Event Smoking Study

Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

Electronic Cigarettes and Reactivity to Smoking Cues

VISIBILITY™ Iliac Study

The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants

Optimizing Tobacco Dependence Treatment in the Emergency Department

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion

MRI Guided Prostate Cancer Focal Laser Ablation

A Sample Collection Study Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits

Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Effectiveness of Silver Diamine Fluoride (SDF) in Arresting Cavitated Caries Lesions

Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions.

Shape-sensing Versus Electromagnetic Robotic Bronchoscopy for Evaluation of PulmoNary LEsions

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

The Asahi Intecc PTCA Chronic Total Occlusion Study

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Structural Stability of Carotid Plaque and Symptomatology

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions